2021 Estimated revenue is expected to meet or exceed top end of guided range of $89-93 million
Delivered 28,118 gene expression profile test reports in 2021, an increase of 55% compared to 2020
Year-end 2021 cash and cash equivalents expected to be approximately $330 million
https://finance.yahoo.com/news/castle-biosciences-announces-preliminary-fourth-120000875.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.